Inspire Medical Systems, Inc. Accounts Receivable, Allowance for Credit Loss, Recovery
Inspire Medical Systems, Inc. (INSP) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $596.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2026-02-13
- Inspire Medical Systems, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2025-12-31 was $36.00K, a 52.00% decline year-over-year.
- Inspire Medical Systems, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2025-09-30 was $310.00K, a 222.92% increase year-over-year.
- Inspire Medical Systems, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2024-12-31 was $75.00K.
- Inspire Medical Systems, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2024-09-30 was $96.00K.
- Inspire Medical Systems, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2025 was $596.00K, a 248.54% increase from fiscal 2024.
- Inspire Medical Systems, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2024 was $171.00K.
- Inspire Medical Systems, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2023 was $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|---|---|
| 2025-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $346.00K derived: sum of 2 quarters · filed 2026-02-13 | $596.00K 10-K · filed 2026-02-13 | |
| 2025-09-30 | $310.00K 10-Q · filed 2025-11-03 | $560.00K 10-Q · filed 2025-11-03 | ||
| 2024-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $171.00K derived: sum of 2 quarters · filed 2026-02-13 | $171.00K 10-K · filed 2026-02-13 | |
| 2024-09-30 | $96.00K 10-Q · filed 2025-11-03 | $96.00K 10-Q · filed 2025-11-03 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |